Genedata completes important milestone in collaboration with Bayer Pharma AG

Genedata completes important milestone in collaboration with Bayer Pharma AG

 

Successful integration of Genedata Profiler™ allows researchers to access, process, analyze and manage petabytes of NGS and other omics data from patients and pre-clinical experiments. New platform breaks up traditional data silos by ensuring patient privacy, security, and full chain of custody for the entire data analysis process.

London, UK, September 23, 2015

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced the successful delivery of an important milestone in its collaboration with Bayer Pharma AG to create an advanced security-hardened research data platform to manage, process and analyze exploratory NGS and other omics data from patients and pre-clinical experiments. The platform is based on Genedata Profiler, an open, interoperable enterprise software system designed to facilitate efficient patient and compound profiling processes. Genedata Profiler was launched by Genedata in April this year and is available immediately to interested parties.

Pharmaceutical companies are continuously accelerating the development of drugs that efficiently treat a targeted, molecular sub-population of patients. Integral to this aim is the ability to delve deeper into omics data from patients and patient-derived models in order to increase knowledge about specific disease states and drug treatment responses.

Harnessing the data storage and virtualization capabilities of iRODS, an open source middleware software system, to the data management, processing and analysis power of Genedata Profiler, Bayer Pharma AG and Genedata have created a research data platform to maximize the utility and usability of the vast amounts of patient-related multi-omics data available. The integration of Genedata Profiler with iRODS ensures chain of custody of the entire omics data analysis workflow, thereby significantly enhancing the security of the data and ensuring the privacy of patients being studied. The platform enables researchers to work with data from clinical and preclinical environments, linking traditionally disconnected R&D data silos.

Genedata Profiler enables integration of disease and genomic information from different studies and facilitates research teams in geographically distributed environments to securely manage, share and analyze on a global scale the clinical multi-omics data amassed during their translational research efforts. It translates NGS data into knowledge for target and biomarker discovery and patient selection, and to generate reproducible, reliable conclusions about disease causes, risks, and drug responses. At the same time, increasingly complex compliance and data management challenges in the areas of patient privacy and security are met by the cutting-edge security features of Genedata Profiler, establishing a chain of custody for analyzing personalized medicine data.

"We are pleased that our successful collaboration with Bayer Pharma AG has resulted in the establishment of a state-of-the-art translational research data platform that allows interdisciplinary and geographically dispersed teams of researchers to work with patient-related NGS data. This solution ensures that only properly authenticated and authorized researchers have access to this sensitive information," said Dr. Othmar Pfannes, CEO of Genedata. "Genedata Profiler moves applied precision medicine into a new era, where petabytes of genomic data can be securely accessed, shared, analyzed and interpreted on a global scale. We are committed to the continued development of Genedata Profiler to make it the platform of choice for all omics-based profiling processes for patients and compounds."

Genedata is the trusted partner of all 25 of the top 25 pharma companies for R&D software solutions. Genedata Profiler will be demonstrated at the 13th Annual Pharmaceutical IT Congress 2015 in London, September 23–24, 2015.

About Genedata

Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US.

Follow Genedata on LinkedIn

Disclaimer

The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Press Contact

Allison Kurz
Public Relations
+41 61 511 8459
pr@genedata.com

 

Read more on